Search Results

You are looking at 1 - 10 of 25 items for :

  • "polycythemia vera" x
Clear All
Orvosi Hetilap
Authors: Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon, Ádám Kellner, Éva Karádi, Erika Valasinyószki, Miklós Udvardy and Miklós Egyed

neoplasms. Eur J Haematol. 2015; 95: 270–279. 3 Tefferi A. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J

Open access

thrombocythemia, polycythemia vera, and myelofibrosis. Blood, 2014, 124 (16), 2507–2513. 2 Tefferi, A.: Polycythemia vera and essential thrombocythemia: 2012 update on

Restricted access

polycythemia vera. J. Biol. Chem., 2005, 280 , 22788–22792. Li Z. Identification of an acquired JAK2 mutation in polycythemia vera J. Biol. Chem

Restricted access

T. Impact of therapy on the development of second malignancies in essential thrombocythemia and polycythemia vera: Are we comfortable about this? Leuk Lymphoma 2016; 57: 6

Restricted access

Irodalom 1 Dombi P, Illés Á, Demeter J, et al. Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the Polycythemia vera

Restricted access
Orvosi Hetilap
Authors: Tünde Krähling, Katalin Balassa, Nóra Meggyesi, András Bors, Judit Csomor, Árpád Bátai, Gabriella Halm, Miklós Egyed, Sándor Fekete, Péter Reményi, Tamás Masszi, Attila Tordai and Hajnalka Andrikovics

constitutive signalling causes polycythaemia vera. Nature, 2005, 434 (7037), 1144–1148. Kralovics, R., Passamonti, F., Buser, A. S., et al.: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J

Open access

thrombocythemia and polycythemia vera. Eur. J. Haematol., 2016, 96 (3), 285–290. 32 Szerafin, L., Jakó, J.: Chronic myeloid leukaemia following polycythaemia

Restricted access
Orvosi Hetilap
Authors: Hajnalka Andrikovics, Anikó Szilvási, Nóra Meggyesi, Viktória Király, Gabriella Halm, Sándor Lueff, Sarolta Nahajevszky, Gábor Mikala, Andrea Sipos, Nóra Lovas, Zoltán Csukly, Zoltán Mátrai, Júlia Tamáska, Attila Tordai and Tamás Masszi

Campbell, P. J., Scott, L. M., Buck, G. és mtsai Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 2005, 366 , 1945

Restricted access
Orvosi Hetilap
Authors: Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon, Miklós Udvardy and Miklós Egyed

. Med., 2013, 369 (25), 2379–2390. 3 Moulard, O., Mehta, J., Fryzek, J., et al.: Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European

Open access
Orvosi Hetilap
Authors: János László Iványi, Éva Marton, Márk Plander and Tamás Szendrei

Tefferi, A.: Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am. J. Hematol., 2013, 88 (6), 507–516. 3

Restricted access